Official Title :    A Study to Evaluate Maintenance of Hair Regrowth Following Dose Reduction
NCT Number :  [STUDY_ID_REMOVED]  
Document Dates :   Protocol Amendment 3: 09 September 2022       of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata 
CTP-543 08 January 2021 
Protocol CP543.2004 Concert Pharmaceuticals, Inc. 
CONFIDENTIAL & PROPRIETARY 5 1. SUMMARY OF CHANGES : AMENDMENT 1.1 (08 January 2021)
A Study to Evaluate Maintenance of Hair Regrowth Following Dose Reduction of CTP-543 
in Adult Patients with Moderate to Severe Alopecia Areata 
CP543.2004, Protocol Amendment #1 dated 07 January 2021 
Amendment #1.1 dated 08 January 2021 
The main purpose of this amendment #1 to original protocol dated 13 November 2020, is to 
modify the Schedule of Assessments and Section 11.3 (Photographs). Photographs of the scalp 
will be taken at any time a SALT assessment is performed throughout the course of the study.  
ments for the Photography line 
item and modifications to the language in Section 11.3 have been made.  Additionally, a clerical 
error was identified in the Schedule of Assessments where a pregnancy test at Week 28 of Part 
A, Period 2 was erroneously missed.  The error has been corrected.  
CTP-543 07 January 2021 
Protocol CP543.2004 Concert Pharmaceuticals, Inc. 
CONFIDENTIAL & PROPRIETARY 5 1. SUMMARY OF CHANGES : AMENDMENT 1 (07 January 2021)
A Study to Evaluate Maintenance of Hair Regrowth Following Dose Reduction of CTP-543 
in Adult Patients with Moderate to Severe Alopecia Areata 
CP543.2004, Protocol Amendment #1 
07 January 2021 
The main purpose of this amendment #1 to original protocol dated 13 November 2020, is to 
modify the Schedule of Assessments and Section 11.3 (Photographs). Photographs of the scalp 
will be taken at any time a SALT assessment is performed throughout the course of the study.  
sequently added to the Schedule of Assessments for the Photography line 
item and modifications to the language in Section 11.3 have been made.  